Merck (MRK) Interest & Investment Income (2010 - 2013)
Merck's (MRK) quarterly Interest & Investment Income came in at $57.0 million in Q1 2013, up 3.64% year-over-year from $55.0 million in Q1 2012, and down 24.0% quarter-over-quarter from $75.0 million in Q4 2012.
Analysis
Merck (MRK) Interest & Investment Income (2010 - 2013) Analysis & Trends
Merck (MRK) has reported Interest & Investment Income for 4 consecutive years, with $57.0 million the latest figure, recorded in Q1 2013.
- On a quarterly basis, Interest & Investment Income rose 3.64% year-over-year to $57.0 million in Q1 2013; TTM through Mar 2013 was $234.0 million, a N/A change from a year earlier, with the FY2012 full-year figure at $232.0 million, up 60.0% from the prior year.
- Interest & Investment Income was $57.0 million for Q1 2013 at Merck, down from $75.0 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $75.0 million in Q4 2012 and troughed at $31.0 million in Q4 2010.
- A 4-year average of $48.6 million and a median of $47.0 million in 2012 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 74.42% in 2012 and rose 3.64% in 2013, its largest moves.
- Over 4 years, Interest & Investment Income stood at $31.0 million in 2010, then jumped by 38.71% to $43.0 million in 2011, then jumped by 74.42% to $75.0 million in 2012, then decreased by 24.0% to $57.0 million in 2013.
- The last three Interest & Investment Income figures came in at $57.0 million (Q1 2013), $75.0 million (Q4 2012), and $47.0 million (Q3 2012), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 89.50 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 35.58 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 27.90 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 38.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 57.00 Mn |
| Dec 31, 2012 | 75.00 Mn |
| Sep 30, 2012 | 47.00 Mn |
| Mar 31, 2012 | 55.00 Mn |
| Dec 31, 2011 | 43.00 Mn |
| Sep 30, 2011 | 32.00 Mn |
| Dec 31, 2010 | 31.00 Mn |